Application 020789
- Type
- NDA
- Sponsor
- SUNOVION PHARMS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ZONEGRAN | ZONISAMIDE | CAPSULE;ORAL | 100MG | Yes | Yes |
| 002 | ZONEGRAN | ZONISAMIDE | CAPSULE;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | ZONEGRAN | ZONISAMIDE | CAPSULE;ORAL | 25MG | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 59212-680 | Zonegran | Zonisamide | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-680 | Zonegran | zonisamide | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-680 | Zonegran | Zonisamide | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-680 | Zonegran | Zonisamide | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-681 | Zonegran | Zonisamide | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-681 | Zonegran | zonisamide | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-681 | Zonegran | Zonisamide | Concordia Pharmaceuticals Inc. | NDA | Current |
| 59212-681 | Zonegran | Zonisamide | Concordia Pharmaceuticals Inc. | NDA | Current |